6 min read
Milestone Monday
Milestone Monday: Biopharma IPOs Are Playing To A Friendly House
ADARx, the year's 22nd US drug developer IPO, closed Oct. 1 above its offer price. The bigger story is life after opening night: one hair loss developer ended Oct. 1 near seven times its offer price, and listed companies are finding new money on terms that need a careful read.
